Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
企業コードTMCI
会社名Treace Medical Concepts Inc
上場日Apr 23, 2021
最高経営責任者「CEO」Treace (John T)
従業員数477
証券種類Ordinary Share
決算期末Apr 23
本社所在地100 Palmetto Park Place
都市PONTE VEDRA
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号32081
電話番号19043735940
ウェブサイトhttps://www.treace.com/
企業コードTMCI
上場日Apr 23, 2021
最高経営責任者「CEO」Treace (John T)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし